A week after the U.S. Food and Drug Administration (FDA) announced a shortage of immediate-release mixed amphetamine salts, commonly known by the brand name Adderall, Google searches for “caffeine vs. Adderall” surged.
The FDA publicized the Adderall deficiency on October 12 on its Drug Shortages website. She explained in a press release that a manufacturer of mixed salts for amphetamines, Teva, is “experiencing ongoing intermittent manufacturing delays.”
“Other manufacturers continue to produce mixed amphetamine salts, but there is insufficient supply to continue to meet US market demand from these manufacturers,” the press release said.
Amphetamine mixed salts like Adderall are FDA-approved to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. According to the Centers for Disease Control and Prevention (CDC), a child with ADHD may have trouble paying attention, controlling impulsive behavior, and being overly active. Narcolepsy can be associated with “excessive daytime sleepiness” and sudden muscle weakness, the CDC said.
“Until supplies are restored, there are alternative therapies, including the extended-release version of amphetamine mixed salts, available to healthcare professionals and their patients for the approved indications of amphetamine mixed salts,” the FDA said in the press release. “Patients should work with their healthcare professionals to determine their best treatment option.”
The fact that “caffeine vs. Adderall” has become a groundbreaking search query on Google since the FDA announced the shortage may reflect public interest in potential alternatives to the drug. Both Adderall and caffeine are considered stimulants, meaning they can help people become more alert and alert, and can even be used to try to improve focus and memory, according to an article by GoodRX Health that Written by Austin Ulrich, a Board Certified Home Nursing Clinical Pharmacist.
Ulrich wrote that it’s not recommended for people to substitute caffeinated products for medications like Adderall, but noted that some research suggests caffeine may help with some parts of cognitive performance. He cited a 2016 review study that found that low or moderate amounts of caffeine can improve alertness, alertness, attention, and reaction time. However, the study found that “less consistent effects” were observed in relation to memory, judgment and decision-making.
The FDA said it will continue to monitor the supply of drug and device manufacturers “with whatever is necessary to address the deficiency.” It also said it would update its website with any new information about amphetamine mixed salts supply as it emerged.
“We continue to use all the tools at our disposal to maintain patient care and will provide public updates regarding the Adderall shortage,” the FDA wrote.
The administration did not elaborate on the cause of manufacturer Teva’s ongoing delays, nor did it provide a forecast as to when the problems would be resolved.
news week contacted the FDA for further comments.
https://www.newsweek.com/caffeine-internet-searches-increase-fda-announces-adderall-shortage-amphetamine-mixed-salts-1752851 Caffeine searches are on the rise after the FDA announced a nationwide Adderall deficiency